专利信息

首页 1 2 3 4 5 6 下页尾页共 452 条记录, 当前第1/46页。

专利标题：A kind of preparation method of hydroxyl naphthoic acid salmeterol

专利标题：Processes suitable for the preparation of salmeterol

The present invention relates to processes for the preparation of 4-hydroxy-alpha'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-13-benzenedimethanol 1-hydroxy-2-naphthoate (salmeterol xinafoate) (12a) the preparation of 4-hydroxy-alpha'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-13-benzenedimethanol (salmeterol) (11) the preparation of protected N-[6-(4-phenylbutoxy)hexyl]amine intermediates (7) and the preparation of 6-substituted (4-phenylbutoxy)hexane intermediates (5) shown below wherein X is a le...

专利标题：Synergistic combination roflumilast and salmeterol

专利权人：Takeda Gmbh, De;

The invention relates to the combined administration of PDE inhibitors and ² 2 adrenoceptor agonists for the treatment of respiratory tract disorders.

专利标题：DRY POWDER FOR INHALATION FORMULATION COMPRISING SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND TIOTROPIUM BROMIDE, AND METHOD FOR PREPARING THE SAME

专利权人：HANMI PHARM IND CO LTD [KR];

专利标题：Method for synthesizing (R)-salmeterol

专利权人：UNIV NANJING;

专利标题：Salmeterol preparation method

专利标题：INHALATION PREPARATION FOR TREATING RESPIRATORY DISEASES CONTAINING MICRONISED SALMETEROL XINAFOATE AND MICRONISED FLUTICASONE PROPIONATE AS ACTIVE SUBSTANCES AND METHOD FOR PREPARING IT

专利权人：SHOLEKS DEV GMBKH [SC];

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine and pharmaceutical industry and concerns a dry powder preparation containing micronised: salmeterol xinafoate and fluticasone propionate. The preparation contains a carrier consisting of lactose of average particle size 100-120 mcm and sodium benzoate. What is also described is a method for producing the preparation.EFFECT: formulation possesses higher percentage of a respirable fraction of the active substances.4 cl, 8 ex

专利标题：Salmeterol/fluticasone aerosol preparation with hydrofluoroalkane as propellent

专利标题：PHARMACEUTICAL COMPOSITION FOR INHALATION

专利权人：SANOFI SA;

594026 Disclosed is a method for setting the fine particle dose (FPD) characteristics of a pharmaceutical composition for inhalation, wherein the composition comprises the two active ingredients salmeterol ((RS)-2-(hydroxymethyl)-4-{ 1-hydroxy-2-[6-(4-phenylbutoxy) hexylamino]ethyl} phenol) and flucitasone (S-(fluoromethyl)(6S,8S,9R,10S,11S,13S,14S, 16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate) or pharmaceu...

专利标题：Process for the preparation of salmeterol and its salts

专利权人：GENERICS UK LTD [GB];

The present invention relates to processes for the preparation of 4-hydroxy-+-'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-hydroxy-2-naphthoate (salmeterol xinafoate) (12a), the preparation of 4-hydroxy-+-'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (salmeterol) (11), the preparation of protected N-[6-(4-phenylbutoxy)hexyl]amine intermediates (7), and the preparation of 6-substituted (4-phenylbutoxy)hexane intermediates (5), shown below, wherein X is a l...

当前查询条件: [药品] 包含 'Salmeterol'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103641727A	2014/3/19
专利标题：A kind of preparation method of hydroxyl naphthoic acid salmeterol 专利权人：

2. US8648214B2	2014/2/11
专利标题：Processes suitable for the preparation of salmeterol 专利权人：Merck Development Centre Private Limited; The present invention relates to processes for the preparation of 4-hydroxy-alpha'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-13-benzenedimethanol 1-hydroxy-2-naphthoate (salmeterol xinafoate) (12a) the preparation of 4-hydroxy-alpha'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-13-benzenedimethanol (salmeterol) (11) the preparation of protected N-[6-(4-phenylbutoxy)hexyl]amine intermediates (7) and the preparation of 6-substituted (4-phenylbutoxy)hexane intermediates (5) shown below wherein X is a le...

3. HU229439B1	2013/12/30	HU20020003098	2000/8/11
专利标题：Synergistic combination roflumilast and salmeterol 专利权人：Takeda Gmbh, De; The invention relates to the combined administration of PDE inhibitors and ² 2 adrenoceptor agonists for the treatment of respiratory tract disorders.

4. KR20130140358A	2013/12/24	KR20120063665	2012/6/14
专利标题：DRY POWDER FOR INHALATION FORMULATION COMPRISING SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND TIOTROPIUM BROMIDE, AND METHOD FOR PREPARING THE SAME 专利权人：HANMI PHARM IND CO LTD [KR];

5. CN103435505A	2013/12/11	CN20131400022	2013/9/5
专利标题：Method for synthesizing (R)-salmeterol 专利权人：UNIV NANJING;

6. CN103420856A	2013/12/4	CN20131319734	2013/7/25
专利标题：Salmeterol preparation method 专利权人：ASYMCHEM LAB TIANJIN CO LTD;ASYMCHEM LIFT SCIENCE TECHNOLOGY TIANJIN CO LTD;TIANJIN ASYMCHEM PHARMACY CO LTD;ASYMCHEM MEDICAL CHEMICAL FUXIN TECHNOLOGY CO LTD;JILIN ASYMCHEM MEDICAL CHEMICAL CO LTD;

7. RU2494730C1	2013/10/10	RU20120111688	2012/3/27
专利标题：INHALATION PREPARATION FOR TREATING RESPIRATORY DISEASES CONTAINING MICRONISED SALMETEROL XINAFOATE AND MICRONISED FLUTICASONE PROPIONATE AS ACTIVE SUBSTANCES AND METHOD FOR PREPARING IT 专利权人：SHOLEKS DEV GMBKH [SC]; FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine and pharmaceutical industry and concerns a dry powder preparation containing micronised: salmeterol xinafoate and fluticasone propionate. The preparation contains a carrier consisting of lactose of average particle size 100-120 mcm and sodium benzoate. What is also described is a method for producing the preparation.EFFECT: formulation possesses higher percentage of a respirable fraction of the active substances.4 cl, 8 ex

8. CN102366406B	2013/10/9
专利标题：Salmeterol/fluticasone aerosol preparation with hydrofluoroalkane as propellent 专利权人：Jiangyin Changfeng Medical Technology Co.,ltd.;

9. NZ594026A	2013/9/27	NZ20100594026	2010/2/18
专利标题：PHARMACEUTICAL COMPOSITION FOR INHALATION 专利权人：SANOFI SA; 594026 Disclosed is a method for setting the fine particle dose (FPD) characteristics of a pharmaceutical composition for inhalation, wherein the composition comprises the two active ingredients salmeterol ((RS)-2-(hydroxymethyl)-4-{ 1-hydroxy-2-[6-(4-phenylbutoxy) hexylamino]ethyl} phenol) and flucitasone (S-(fluoromethyl)(6S,8S,9R,10S,11S,13S,14S, 16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate) or pharmaceu...

10. EP2641893A1	2013/9/25	EP20130154981	2006/10/17
专利标题：Process for the preparation of salmeterol and its salts 专利权人：GENERICS UK LTD [GB]; The present invention relates to processes for the preparation of 4-hydroxy-+-'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-hydroxy-2-naphthoate (salmeterol xinafoate) (12a), the preparation of 4-hydroxy-+-'-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (salmeterol) (11), the preparation of protected N-[6-(4-phenylbutoxy)hexyl]amine intermediates (7), and the preparation of 6-substituted (4-phenylbutoxy)hexane intermediates (5), shown below, wherein X is a l...

下载范围

下载内容